George’s area of research is haematological cancers with a particular focus on myeloid leukaemias and clonal haematopoiesis. His group investigates their pathogenesis, clonal evolution and therapeutic vulnerabilities. The ultimate aim of their work is to develop new effective therapies and approaches for the early detection and prevention of myeloid malignancies.